# v3.13

## Related releases

## Data changes

Gene:
AFF4 Gene Background Updated
AFF4 Gene Summary Updated
KMT2A Gene Background Updated
KMT2C Gene Background Updated
KMT2D Gene Background Updated
PIWIL1 Gene Summary Updated
PIWIL1 Gene Background Updated

Alteration:
AFF4 Gene Type Updated
AFF4 Y256C Added
BRCA1 S1164I, Mutation Effect Description Updated
BRCA1 R1495K, Mutation Effect Description Updated
BRCA1 L22S, Mutation Effect Description Updated
KEAP1 G333C, Mutation Effect Description Updated
PIWIL1 Gene Type Updated
PPP2R2A E83* Name Changed
	 New: E83*
	 Old: G247T
PPP2R2A E83*, Mutation Effect Description Updated
RAD51C L138F, Mutation Effect Description Updated
RAD51C D159N, Mutation Effect Description Updated
RAD51C R258H, Mutation Effect Description Updated
SETBP1 T864, Mutation Effect Description Updated
SETBP1 I865, Mutation Effect Description Updated
TP53 G334R, Oncogenicity Updated
	 New: Likely
	 Old: Likely Neutral
Evidence:
ALK Fusions, Inflammatory Myofibroblastic Tumor, Crizotinib  Updated
EGFR G719, Non-Small Cell Lung Cancer, Osimertinib 2 Added
EGFR S768I, Non-Small Cell Lung Cancer, Osimertinib 2 Added
EGFR L861Q, Non-Small Cell Lung Cancer, Osimertinib 2 Added
FGFR2 Fusions, Cholangiocarcinoma, Futibatinib 3A Added
KRAS G12C, Pancreatic Adenocarcinoma, Sotorasib 3A Added
KRAS G12C, Pancreatic Adenocarcinoma, Tumor Type Summary Updated
MET Amplification, Non-Small Cell Lung Cancer, Tepotinib 2 Added
MET Amplification, Non-Small Cell Lung Cancer, Tumor Type Summary Updated
MET Amplification, Non-Small Cell Lung Cancer, Capmatinib 2 Added
ROS1 Fusions, Non-Small Cell Lung Cancer, Ceritinib 2 Added
ROS1 Fusions, Non-Small Cell Lung Cancer, Lorlatinib 2 Added
